These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1977709)

  • 21. [Respiratory gas exchange. Anesthesia with enflurane or isoflurane in nitrous oxide during spontaneous and controlled ventilation].
    Bengtson JP; Arnestad JP; Bengtsson J; Bengtsson A; Stenqvist O
    Anaesthesist; 1993 May; 42(5):273-9. PubMed ID: 8317683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of almitrine and oxygen on ventilation and gas exchange in patients with chronic respiratory insufficiency.
    Hawryłkiewicz I; Jedrzejewska-Makowska M; Górecka D; Zieliński J
    Eur J Respir Dis; 1983 Oct; 64(7):512-6. PubMed ID: 6138276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
    Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
    Malerba M; Boni E; Romagnoni G; Filippi B; Politi A; Giustina A; Tantucci C; Grassi V
    Monaldi Arch Chest Dis; 1994 Dec; 49(5):389-93. PubMed ID: 7841973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
    Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of broxaterol in asthmatic children].
    Flores D'Arcais A; Crippa L; De Biase D; Romagnoni G
    Minerva Pediatr; 1992 Sep; 44(9):421-5. PubMed ID: 1361960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.
    Malerba M; Boni E; Tantucci C; Filippi B; Romagnoni G; Grassi V
    Respiration; 1996; 63(1):8-16. PubMed ID: 8833987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary effects of intravenous atropine induce ventilation perfusion mismatch.
    Gaspari RJ; Paydarfar D
    Can J Physiol Pharmacol; 2014 May; 92(5):399-404. PubMed ID: 24773405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.
    Robuschi M; Scuri M; Spagnotto S; Gambaro G; Lodola E; Pisati R; Bianco S
    Eur J Clin Pharmacol; 1995; 47(5):465-6. PubMed ID: 7720771
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of protein intake on pulmonary gas exchange and ventilatory drive in postoperative patients.
    Delafosse B; Bouffard Y; Bertrand O; Viale JP; Annat G; Motin J
    Anesthesiology; 1989 Mar; 70(3):404-7. PubMed ID: 2493752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake of broxaterol by cultured human cells.
    Parenti P; Cappelletti G; Fornasini G; Galimberti C; Hanozet G
    Biochem Int; 1992 Nov; 28(3):467-74. PubMed ID: 1362350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
    Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute ventilatory and gas-exchange effects of a new beta-2 agonist, broxaterol, in asthmatics.
    Tantucci C; Burni B; Dottorini ML; Malerba M; Peccini F; Gurrieri G; Sorbini CA; Grassi V
    Int J Clin Pharmacol Res; 1990; 10(3):183-9. PubMed ID: 1977709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
    Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
    Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
    Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gas exchange in acute respiratory distress syndrome].
    Raimondi GA
    Medicina (B Aires); 2003; 63(2):157-64. PubMed ID: 12793087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.